A phase I/II study of adoptive SARS-CoV-2-specific T cells in immunocompromised hosts with or at risk of severe COVID-19 infection
-
Published:2024-05
Issue:
Volume:
Page:
-
ISSN:1465-3249
-
Container-title:Cytotherapy
-
language:en
-
Short-container-title:Cytotherapy
Author:
Seng Michaela Su-fernORCID,
Ng King PanORCID,
Soh Teck Guan,
Tan Thuan Tong,
Chan MarietaORCID,
Maiwald MatthiasORCID,
Tan Lip Kun,
Linn Yeh ChingORCID,
Leung WingORCID